Daniel Dolan
Officer at Nabriva Therapeutics plc (NBRV) since March 2021
Daniel Dolan has filed 4 insider reports with the SEC since March 2021, as officer at Nabriva Therapeutics plc (NBRV). The latest filing, on August 16, 2022, reports exercise or conversion of a derivative at Nabriva Therapeutics plc (NBRV).
- Filings
- 4
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where Daniel Dolan is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Officersince March 2021 | Aug 16, 2022 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Aug 11, 2022NBRVSEC Form 4 filed by Dolan DanielForm 4Exercise or conversion of a derivative
- Jan 28, 2022NBRVSEC Form 4 filed by Dolan DanielForm 4Grant or award
- Mar 31, 2021NBRVSEC Form 4 filed by Daniel DolanForm 4Grant or award
- Mar 12, 2021NBRVSEC Form 3 filed by Daniel DolanForm 3New insider
Compare Daniel Dolan with
- Daniel Dolan vs H Michael Hogan III1 shared
- Daniel Dolan vs Steven P. Gelone1 shared
- Daniel Dolan vs Theodore R Schroeder1 shared
- Daniel Dolan vs J. Christopher Naftzger1 shared
- Daniel Dolan vs Christine J. Guico-Pabia1 shared
- Daniel Dolan vs Daniel D Burgess1 shared
Questions about Daniel Dolan
- What is Daniel Dolan's role at Nabriva Therapeutics plc?
- Daniel Dolan reports to the SEC as officer at Nabriva Therapeutics plc (NBRV), according to the latest filing on August 16, 2022.
- Has Daniel Dolan bought or sold stock recently?
- No open-market purchases or sales by Daniel Dolan are on file. The filings report exercise or conversion of a derivative and grant or award.
- How do I get alerts when Daniel Dolan files?
- Follow Daniel Dolan on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Daniel Dolan (SEC CIK 0001826818). Totals count each trade once, skipping amendments whose original is on file, from Mar 16, 2021 on. View on SEC EDGAR